{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:06Z","timestamp":1791286626366,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsbmb.2016.03.020","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T23:52:18Z","timestamp":1458604338000},"page":"154-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Genetic disorders in primary aldosteronism\u2014familial and somatic"],"prefix":"10.1016","volume":"165","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.03.020_bib0005","first-page":"1109","article-title":"Hypertension increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jcem-27-2-300","article-title":"A new form of congenital adrenal hyperplasia","volume":"27","author":"New","year":"1967","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0015","first-page":"1","article-title":"Non-tumorous primary aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism)","volume":"101","author":"Salti","year":"1969","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0020","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198110223051712","article-title":"Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone?","volume":"305","author":"Mulrow","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimeric 11-beta-hydroxylase aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0030","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nsb0197-32","article-title":"The amino acid substitutions Ser288Gly and Val320A la convert the cortisol producing enzyme CYP11B1, into an aldosterone producing enzyme","volume":"4","author":"Curnow","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1445-5994.1997.tb00999.x","article-title":"R.D. Gordon. A PCR-based method of screening individuals of all ages, from neonates to the elderly for familial hyperaldosteronism type I","volume":"27","author":"Stowasser","year":"1997","journal-title":"Aust. N.Z. J. Med."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0045","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0050","first-page":"3214","article-title":"Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene","volume":"83","author":"Torpy","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0055","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/jhh.2010.93","article-title":"Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II","volume":"25","author":"Carrs","year":"2011","journal-title":"J. Hum. Hypertens"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0065","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Endocrine society. case detection: diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism the PATOGEN study (Primary aldosteronism in torino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertens"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0075","first-page":"2150229","article-title":"The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience","volume":"44","author":"Pallauf","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Europ. J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0085","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hypersecretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0090","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0100","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0105","article-title":"Bilateral idiopathic adrenal hyperplasia: genetics and beyond","author":"Zennaro","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germlineCACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0115","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0120","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence: clinical and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertens"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Gen."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat. Gen."},{"issue":"August","key":"10.1016\/j.jsbmb.2016.03.020_bib0135","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","author":"Scholl","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J. Atheros. Thromb."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0155","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertens"},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0160","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.03.020_bib0165","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"16","author":"Willliams","year":"2015","journal-title":"Hypertens"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007601630067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007601630067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:53:07Z","timestamp":1760745187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007601630067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"alternative-id":["S096007601630067X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.020","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic disorders in primary aldosteronism\u2014familial and somatic","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}